Skip to main navigation
Skip to main content
Skip to page footer
Back
Nephrolytix
Nephrolyx (Nephrolytix GmbH) is a Charité Berlin spin-off developing an in-vitro diagnostic test and digital platform for highly precise and rapid measurement of kidney function (True GFR). The technology combines a proprietary database with algorithms analyzing contrast agent measurements to diagnose acute kidney injury (AKI) within just a few hours. Target users include hospitals, clinical laboratories, and treating physicians.
